Who are the key players in Europe Ovarian Cancer Diagnostics and Therapeutics Market?

F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Johnson and Johnson (Janssen Pharmaceuticals), Eli Lilly and Company and GlaxoSmithKline PLC are the major companies operating in the Europe Ovarian Cancer Diagnostics and Therapeutics Market. Read More

Europe Ovarian Cancer Diagnostics and Therapeutics Market

Europe Ovarian Cancer Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Europe Ovarian Cancer Diagnostics and Therapeutics Market is Segmented by Cancer Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, and Other Cancer Types), Modality (Diagnosis and Therapeutics), and Geography (Germany, the UK, France, Spain, Italy, and the Rest of Europe). The report offers the value (in USD million) for the above segments.

Europe Ovarian Cancer Diagnostics and Therapeutics Industry Overview

The European ovarian cancer diagnostics and therapeutics market consists of several major players and is moderately fragmented. The key players in the market include AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline PLC, Johnson and Johnson, Amneal Pharmaceuticals, Siemens Healthineers AG, among others.